3 ms·
Well it looks nice and shiny! But I'm afraid it's absolutely a revamp of uBiome. This sort of remote diagnosis simply can't be done to any degree of accuracy wi
by jaggs 4y ago
Well it looks nice and shiny! But I'm afraid it's absolutely a revamp of uBiome. This sort of remote diagnosis simply can't be done to any degree of accuracy with a single pinprick blood sample. You need a significant program of investigation before you can start trying to isolate what you're looking for. Diagnosis of this type is incredibly complicated because there are so many variables - internal and external - involved.
And at those astronomical costs, the customer will go bust long before any meaningful results/benefits acrue. Not trying to be rude, but this is one of those projects which looks fantastic on a marketing slide deck, but in practice it's woefully inadequate. My only suggestion would be to pivot to a much more focused niche as soon as you can. One which can be reliable with minimal inputs.
- blueyes 4y ago> a revamp of uBiome. That's simply untrue. You shouldn't make wild accusations that you can't back up. Almost everything about Be Golden and uBiome is different. Be Golden is tracking biomarkers associated with inflammation. That is in itself is not a diagnosis. BG is gathering data that clinicians can use to make a diagnosis. uBiome was using swabs, and BG is taking blood. And Be Golden's tech is not solely related to the microbiome, as uBiome was.
- jaggs 4y agohttps://archive.ph/tLNRR https://archive.ph/tLNRR